US 11542326
Anti-IL-25 antibodies and uses thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11542326 (Anti-IL-25 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P